NEW YORK (360Dx) – Numares and the University of Oxford announced on Wednesday a collaboration to develop a test to better diagnose multiple sclerosis patients. 

The in vitro diagnostic test will also improve therapeutic decisions by doctors for MS patients, the partners said in a statement. The test will be based on work done by Oxford researchers differentiating MS patients by metabolic biomarkers using nuclear magnetic resonance spectra. Numares will use its Magnetic Group Signaling technology to advance work by Oxford researchers to create a noninvasive diagnostic. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.